Daiichi Sankyo finds successor to late R&D exec; Versant, Novartis’ kidney biotech poaches Sana CBOnews2024-12-20T12:00:02+00:00December 20th, 2024|Endpoints News|
Aadi starts from scratch as it sells assets, licenses ADCs and raises new fundsnews2024-12-20T11:58:29+00:00December 20th, 2024|Endpoints News|
Florida cancer biotech Syncromune raises $100M Series Anews2024-12-20T11:30:38+00:00December 20th, 2024|Endpoints News|
Updated: Novo’s 23% weight loss with CagriSema falls short of high expectations, new trial plannednews2024-12-20T11:13:59+00:00December 20th, 2024|Endpoints News|
FDA approves Ionis’ treatment for a rare metabolic disordernews2024-12-20T08:36:02+00:00December 20th, 2024|Endpoints News|
FDA rejects Zealand Pharma’s short bowel syndrome drugnews2024-12-19T20:37:45+00:00December 19th, 2024|Endpoints News|
Xcovery nabs first FDA approval for lung cancer drugnews2024-12-19T20:19:55+00:00December 19th, 2024|Endpoints News|
Mesoblast wins long-awaited approval for cell therapynews2024-12-19T20:17:15+00:00December 19th, 2024|Endpoints News|
Payers generally meet drug price watchdog’s ‘fair access’ standards, report saysnews2024-12-19T18:28:30+00:00December 19th, 2024|Endpoints News|
Regeneron forges ahead in factor XI despite field’s mixed resultsnews2024-12-19T18:27:20+00:00December 19th, 2024|Endpoints News|
